Product Information
CIBINQO 100 MG TABLET is a brand product labeled by Pfizer Inc., priced at $196.5694 per EA under NDC 00069033530. Its NADAC has been published 84 times since Nov 20, 2024.
Strength
100 mg/1
Manufacturer
Pfizer Inc.NDC
00069033530
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ABROCITINIBApproval Type
New Drug (NDA)
FDA Application
NDA213871On Market Since
2/24/2022
Pharmacological Classes
Price Statistics
The NADAC for CIBINQO 100 MG TABLET has been published 84 times since Nov 20, 2024, and over the history we have for it it has risen 9.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $196.5694 per EA |
|---|---|
| All-time high | $197.1952 (Jun 10, 2026) |
| All-time low | $180.0955 (Nov 20, 2024) |
| 52-week high | $197.1952 |
| 52-week low | $186.0878 |
| Median price | $189.3303 |
| Average price | $190.6337 |
| Largest weekly change | +5.5% (Dec 31, 2025) |
| Weeks tracked | 84 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the abrocitinib market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CIBINQO 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CIBINQO 100 MG TABLET, manufactured by Pfizer Inc., is $196.5694 per EA (NDC 00069033530), effective Jun 24, 2026.
How has the price of CIBINQO 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for CIBINQO 100 MG TABLET has risen 9.1%. It has been tracked across 84 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for CIBINQO 100 MG TABLET?
Since Nov 20, 2024, the NADAC for CIBINQO 100 MG TABLET has ranged from a low of $180.0955 (Nov 20, 2024) to a high of $197.1952 (Jun 10, 2026), with a median of $189.3303 per EA.
Are there cheaper alternatives to CIBINQO 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CIBINQO 100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CIBINQO 100 MG TABLET?
CIBINQO 100 MG TABLET (NDC 00069033530) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification